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Introduction: The Penn Alcohol Craving Scale (PACS) is one of the most widely used instruments to measure
craving for alcohol. Recent research has suggested that scores on the PACS can be used as a “stand in” for the
diagnostic criterion of alcohol craving with a proposed cutoff of> 20 on the PACS indicating a “positive” al-
cohol craving symptom. The present study examined the convergence between the PACS and face-to-face di-
agnostic interview for the assessment of alcohol craving.
Method: A sample of non-treatment seeking heavy drinkers (N=338) enrolled in experimental studies of AUD
completed the PACS as well as a face-to-face diagnostic interview for AUD, which included the craving item from
the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA).
Results: Using the PACS cut-off score of> 20, 12.9% (N=43) of the sample met criteria for alcohol craving
compared to 21% (N=74) of the sample meeting criteria based on the diagnostic interview. Using the PACS
cutoff of> 20, sensitivity (i.e., true positive rate) was 41% and specificity (i.e., true negative rate) was 95%.
Exploratory analyses suggested that a cut-off score of≥15 achieved the optimal balance of sensitivity (67%) and
specificity (81%) in our sample.
Conclusions: Advancing the assessment of alcohol craving and the conversion from DSM-IV to DSM-5 diagnostic
criteria represents an important research direction. The present study recommends that a PACS score cut off of
≥15 should be used as an indicator of clinically significant alcohol craving in community samples of non-
treatment seekers.
1. Introduction
The symptom of craving has been re-introduced to DSM-5 as one of
the 11 criteria for alcohol use disorder (AUD). This revision to the di-
agnostic system is supported by a host of studies implicating craving in
the phenomenology of AUD, including documenting the experience of
craving in individuals seeking treatment for AUD (Oslin et al., 2009),
association of craving with severity of AUD (MacKillop et al., 2010),
craving as a predictor of relapse to drinking (Higley et al., 2011), and
human laboratory investigations of craving during experimental pro-
vocation (Ray, 2011; Sinha, 2009). In light of the adoption of craving as
a symptom of AUD, questions about the optimal assessment of craving
in clinical populations have been raised, particularly given the lack of
consensus on the development and maintenance of craving (Rosenberg,
2009).
Craving is inherently a subjective experience, marked by the strong
desire to consume a given substance. As reviewed in detail elsewhere
(Ray et al., 2013), there are a host of instruments psychometrically
validated to measure craving for alcohol. Importantly, the assessment of
craving is often divided into tonic and phasic states, with tonic de-
scribing a more stable and unproved experience of craving while phasic
is marked by provocation and short duration of assessment. One of the
most widely used assessments of tonic alcohol craving is the Penn Al-
cohol Craving Scale (PACS) which has demonstrated reliability and
validity (Flannery et al., 2003; Flannery, Volpicelli, & Pettinati, 1999).
As noted by Murphy et al. (2014), using a psychometrically validated
measure of tonic craving such as the PACS can advance the diagnosis of
alcohol craving. To that end, Murphy et al. (2014) proposed a cutoff
of> 20 on the PACS to ascribe a positive “symptom” of alcohol craving.
In a sample of treatment-seekers with AUD, this cutoff resulted in 47%
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of participants meeting criteria for the craving symptom (Murphy et al.,
2014) whereas in our recent study of non-treatment seekers with al-
cohol problems only 16% met for craving based on the same cutoff
(Hartwell & Ray, 2017). Thus, as a new symptom introduced to DSM-5,
the optimal assessment of craving represents a diagnostic challenge to
which the PACS may provide a useful heuristic framework (Murphy
et al., 2014). In other words, the PACS may be used to capture alcohol
craving for diagnostic purposes and to allow a translation from DSM-IV
to DSM-5 diagnostic systems. Though a wide variety of measures, such
as the Obsessive Compulsive Drinking Scale (Anton, Moak, & Latham,
1995), are also designed to capture the experience of tonic alcohol
craving, the PACS benefits from assessing craving as a multi-dimen-
sional experience in a brief, comprehendible, easily scored way that
produces a composite score of the characteristics of craving, rather than
being rooted in aversive or incentive experiences (Flannery et al.,
1999).
In order to advance the application of the PACS as an instrument to
capture the diagnostic symptom of craving, the present study provides a
direct comparison between craving symptom derived by the proposed
PACS cutoff of> 20 (Hartwell & Ray, 2017; Murphy et al., 2014) and
the craving symptom obtained from a face-to-face diagnostic interview
in large sample of community-based non-treatment seeking problem
drinkers that completed the PACS as well as a structured interview for
DSM-5 AUD. The diagnostic assessment of alcohol craving consisted of
the following item: “In situations where you couldn't drink, did you
ever have such a strong desire for it that you could not think of anything
else?” This single item was obtained from the Semi-Structured Assess-
ment for the Genetics of Alcoholism (SSAGA), which included craving
as an ICD-10 symptom (Bucholz et al., 1994). Specifically, this study
addresses the sensitivity and specificity of the PACS cutoff of> 20 in
relation to the assessment of alcohol craving using standard diagnostic
interview methods among non-treatment seekers.
2. Method
2.1. Participants
Non-treatment seeking, heavy alcohol users (N= 338) were re-
cruited from the greater Los Angeles community for participation in
three human laboratory studies of AUD conducted at the University of
California Los Angeles (UCLA). Two studies tested novel pharmacolo-
gical interventions for AUD, specifically ibudilast (Ray et al., 2017a)
and ivermectin (Roche et al., 2016) and a third study tested the re-
lationship between subjective responses to alcohol and progressive
ratio alcohol self-administration (Bujarski et al., 2018). All studies were
approved by the UCLA Institutional Review Board.
Participants were recruited via online and print advertising. After
completion of an initial telephone interview to determine eligibility,
individuals were invited to an in-person interview during which all
measures used in this study were completed. All studies recruited a
community sample of non-treatment seeking heavy drinkers (defined as
self-reported consumption of> 48 drinks/month for psychopharma-
cology studies, defined as outside the NIAAA guidelines (U.S.
Department of Health and Human Services, 2009) for the third study).
All participants were required to be 21 years of age or older. Exclusion
criteria were: (1) in or seeking alcohol treatment, (2) current, self-re-
ported use of psychoactive substances other than marijuana, (3) diag-
nosis of lifetime psychotic or bipolar disorders, (4) pregnancy or refusal
of birth control for women, (5) lack of English fluency.
2.2. Measures
All participants completed a demographic questionnaire querying
age, race, and sex. A master's level clinician, supervised by a licensed
clinical psychologist, administered the Structured Clinical Interview for
DSM (SCID) to assess for current alcohol use disorder according to DSM-
5 criteria; the SCID for DSM-5 was not published at the time of data
collection, thus, the SSAGA item substituted for the craving criterion
question. The Timeline Follow-Back (TLFB; Sobell et al., 1988) assessed
quantity and frequency of alcohol consumption during the past 30 days.
Participants completed the Penn Alcohol Craving Scale (PACS; Flannery
et al., 1999), a 5-item scale scored on a Likert Scale form 0–6. The PACS
benefits from specifically querying frequency, duration, and difficulty
resisting craving over the previous week. To further assess and char-
acterize alcohol use, participants also completed the Alcohol Use Dis-
order Identification Test (AUDIT; Saunders et al., 1993) and the Alcohol
Dependence Scale (ADS; Skinner & Horn, 1984).
2.3. Data analysis
Consistent with the emergent literature, PACS scores were tabulated
and participants placed into correct craving diagnosis based on the
previously determined cut-offs, such that PACS total score> 20 were
considered to meet the threshold of craving on the diagnostic interview,
PACS 15–20 were considered subthreshold, and<15 were considered
non-cravers (Hartwell & Ray, 2017; Murphy et al., 2014). Sensitivity,
the assessment of the test's ability to correctly identify true positives,
and specificity, the ability to capture true negatives, were calculated
using the previously established PACS cut-offs (Hartwell & Ray, 2017;
Murphy et al., 2014) and the diagnostic interview craving question.
Subsequently, in exploratory analyses we tested which cutoff might be
optimal through computing sensitivity and specificity for each possible
PACS score. This was performed by plotting a Receiver Operating
Characteristic (ROC) curve and determining the optimal cutoff as de-
fined by the greatest average sensitivity and specificity within the ROC
curve.
3. Results
Participants were predominantly male (N= 239, 68.3%) and had a
mean age of 32.9 (SD=9.8). They reported drinking an average of 18.5
(SD=6.8) days of the past month and having 6.5 (SD=4.0) drinks per
drinking day. Mean AUDIT score was 17.0 (SD=7.8), indicating that
participants are experiencing significant alcohol related problems and
are likely to meet criteria for alcohol use disorder (i.e., AUDIT > 15
has been associated with significant likelihood of DSM-IV alcohol de-
pendence; (Johnson et al., 2013). The ADS scores were on average 13.3
(SD=7.7), which is indicative of significant alcohol related sympto-
matology. Of the possible ten DSM-5 symptoms (other than alcohol
craving), participants met for an average of 3.1 (SD=2.5) symptoms
and 65.6% of participants met DSM-5 criteria for an AUD.
Seventy-four (21%) participants met criteria for alcohol craving
based on the diagnostic interview. Means PACS score was 11.1
(SD=7.2; full distribution of PACS scores shown in Fig. 1). Using the
recommended PACS cut-off score of> 20, 43 participants (12.9%)
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Fig. 1. Histogram of PACS scores in this sample.
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would meet current craving criteria, with an additional 55 participants
meeting for sub-threshold craving (i.e. scores of 15–20). Using the PACS
cutoff of 20, sensitivity was 41% and specificity was 95%. Based on this
relatively poor sensitivity, we conducted exploratory analyses to de-
termine the optimal cutoff as defined by the greatest average sensitivity
and specificity by examining the Receiver Operating Characteristic
(ROC) curve. Using this approach, we found that a cut-off score of≥15
achieved the optimal balance of sensitivity (67%) and specificity (81%;
Fig. 2). The corresponding positive and negative predictive power va-
lues are 49% and 90%, respectively.
4. Discussion
The goal of the present study was to examine the use of the PACS as
an assessment of alcohol craving in relation to diagnostic interview
data. Implementing the recommended PACS cut-off score of> 20,
12.9% of participants in this study met criteria for alcohol craving.
However, based on clinical interview data which utilized the craving
assessment question from the SSAGA, 21% of the participants endorsed
experiencing alcohol craving in the past 3months. The discrepancy in
prevalence of craving between the PACS-based assessment and the di-
agnostic interview format may be due to how each was assessed, with
the first being a self-report and the latter being a face-to-face interview.
Differences may also be due to the differential in time frame assessed.
The PACS queries past week experiences of craving whereas the diag-
nostic interview sought to capture craving over the previous three
months. Further, the cut-off score of 20 was initially proposed in a
treatment seeking sample (Murphy et al., 2014), which is likely to ex-
hibit higher levels of subjective craving for alcohol compared to their
non-treatment seekers, insofar as treatment seeking samples are in fact
more severe in their clinical presentation than non-treatment seeking
samples (Hartwell & Ray, 2017; Ray et al., 2017b; Rohn et al., 2017).
Thus, it is possible, if not likely, that a threshold established in a
treatment seeking context would be too stringent when generalized to a
non-treatment seeking setting.
To test whether the previously proposed cutoff was appropriate in a
non-treatment seeking context, we then investigated the sensitivity and
specificity of the PACS in relation to the diagnostic interview criterion,
which was used as a gold-standard for diagnostic assessment. Using the
cut-off proposed by Murphy et al. (2014), sensitivity and specificity
were 41% and 95%, respectively. While the calculated specificity was
very high, sensitivity at this cut off level was quite poor which was
consistent with the notion that a cutoff derived in a treatment context
may be too stringent when generalized. Thus, we investigated alter-
native cut offs that may provide an optimal balance between sensitivity
and specificity in our sample. In our data, the cut-off score of ≥15,
optimally balanced sensitivity and specificity with a sensitivity of 67%
and specificity of 81%. Sensitivity and specificity values> 80% are
ideal, however, those above 50% are considered acceptable (Parikh
et al., 2008). While the positive predictive value was moderate, the
negative predictive power was high. Therefore, the PACS cut off of 15
or higher is hereby recommended for capturing the symptom of alcohol
craving in non-treatment seeking samples and achieving a balance be-
tween sensitivity and specificity. Future work should examine this cut-
off in larger populations that includes treatment seekers.
In sum, the present study sought to advance the assessment of
craving for alcohol as a diagnostic criterion for AUD by examining the
performance of a PACS-based assessment in relation to a face-to-face
diagnostic interview. Strengths of this study include the diverse sample
of heavy alcohol users recruited from the community. This type of
sample is representative of those typically recruited for participation in
experimental AUD research. Further, this study utilized reliable and
valid measures to characterize alcohol use and alcohol craving.
Limitations include the moderate sample size for this type of analysis.
Furthermore, these data were collected prior to the publication of the
SCID for DSM-5, therefore necessitating the inclusion of the SSAGA
item to assess for craving. However, the wording of the craving item on
the newly released SCID is rather comparable (First et al., 2015), “Did
you have a strong desire or urge to drink in between those times when
you were using? (Was there a time when you had such strong urges to
use that you had trouble thinking about anything else?)” As craving
represents a diagnostic symptom of AUD with translational properties
(i.e., can be studied under a range of methodologies and samples),
better understanding of the assessment of craving is necessary. As such,
the present study recommends that a PACS score cut off of≥15 be used
as an indicator of clinically significant alcohol craving in community
samples of non-treatment seekers in order to achieve optimal sensitivity
and specificity in relation to the gold-standard face-to-face diagnostic
assessment.
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